3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[2-(2,6-diMethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[2-(2,6-diMethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo- Struktur
1054011-23-2
CAS-Nr.
1054011-23-2
Englisch Name:
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[2-(2,6-diMethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-
Synonyma:
1-Cyclopropyl-7-[4-[2-(2,6-dimethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[2-(2,6-diMethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-
CBNumber:
CB72605811
Summenformel:
C27H28FN3O5
Molgewicht:
493.53
MOL-Datei:
1054011-23-2.mol

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[2-(2,6-diMethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo- Eigenschaften

Siedepunkt:
738.4±60.0 °C(Predicted)
Dichte
1.394±0.06 g/cm3(Predicted)
pka
6.44±0.41(Predicted)

Sicherheit

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[2-(2,6-diMethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo- Chemische Eigenschaften,Einsatz,Produktion Methoden

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[2-(2,6-diMethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[2-(2,6-diMethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Nanjing Chemlin Chemical Co., Ltd 025-83697070
info@chemlin.com.cn China 18077 64

  • 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[4-[2-(2,6-diMethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-
  • 1-Cyclopropyl-7-[4-[2-(2,6-dimethylphenoxy)acetyl]-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
  • 1054011-23-2
Copyright 2019 © ChemicalBook. All rights reserved